|    Join     |    Donate    |   Store    |   About NAMS

Blog: MenoPause ~ take time to think about it

FDA approves first nonhormonal hot flash treatment

by Margery Gass | Jul 03, 2013
Good news for women who have been waiting for an effective nonhormonal treatment for hot flashes: the FDA has just approved the very first nonhormonal therapy in the history of menopause. We have known for awhile that some antidepressants provide relief from hot flashes, but not one was officially approved for that purpose. The newly approved product will be a lower dose of an antidepressant first approved 20 years ago (paroxetine, brand name Paxil). The lower dose approved for hot flashes is called Brisdelle and will probably be available in November. Women who have not found sufficient relief for their moderate or severe hot flashes from lifestyle measures will now have one more option to discuss with their healthcare provider.

Until now, hormone therapy was the only FDA-approved treatment for moderate to severe hot flashes. Some women cannot use hormone therapy for medical reasons or simply prefer not to use it. Brisdelle provides another choice. Although it may not reduce hot flashes as effectively as hormone therapy, it will decrease flashes for most women. Like other drugs, it will not meet the needs of every woman.

Every drug comes with risks and side effects: In clinical trials studying how the drug affected menopausal women, side effects included headache, fatigue, and nausea/vomiting, most commonly occurring in the first week. The label also carries the warning of all antidepressants in this class, that of potentially increasing suicidal thoughts or behavior in the first few months. There is also a possible reduction in the effectiveness of the breast cancer drug tamoxifen if the drugs are used together.



Before posting a comment please review the following policies.

3 Comments

  1. 1 Haley Anthony 31 Oct
    Hello! I am working with my business capstone group to develop a business specifically for menopausal and post-menopausal women. We have a survey to gather primary research to hear women's opinions, reactions, and personal experience with menopause. If you have 5-10 minutes to spare, please take our survey so we can have more results! Thank you!

    https://www.surveymonkey.com/s/BQJ7V27
  2. 2 Lucy Puryear 10 Jul
    Even though it is the first FDA approved drug, there is nothing new about the use of paroxitene for the treatment of hot flashes.  Many of the SSRI's and SNRI's have been studied and show some reduction of hot flashes in some women.  This is same medication found in the brand name Paxil, only prescribed in a lower dose than typically used for depression.  This same treatment could be accomplished more cost effectively by prescribing paroxitine at 10 mg.  There is nothing new about this.
  3. 3 HMM 05 Jul
    RUN!!!  Run as far away from this drug as you possibly can.  Hot Flashes are like a Hawaiian Vacation compared to the withdrawal symptoms you can experience.  Be very, very careful...

Comment

  1.    
     
     
      
       

MenoPause: the blog!

Posts to our Blog are written by NAMS staff members and Dr. Margery Gass. All posts are reviewed and edited by Dr. Gass. We strive to bring you the most recent and interesting information about various aspect of menopause and midlife health. We accept no advertising for our website. We want you to have accurate, unbiased, evidence-based information. 

Margery L.S. Gass, MD, NCMP
NAMS Executive Director

An internationally recognized leader in the field of menopause, Dr. Gass became Executive Director of The North American Menopause Society in 2010. Dr. Gass has been an investigator on numerous research projects, including serving as a principal investigator for the Women’s Health Initiative, and has published and presented on a wide range of topics related to menopause, including osteoporosis, sexual dysfunction, and hormone therapy.

Categories

Recent posts

Copyright© 2014 |  Home  |  Privacy Policy  |   Site Map |
This website is certified by Health On the Net Foundation. Click to verify.

This site complies
with the HONcode
standard
 
for
trustworthy health

information:
verify here.

5900 Landerbrook Drive, Suite 390 - Mayfield Heights, OH 44124, USA
Telephone: 440/442-7550 - Fax: 440/442-2660  - Email: info@menopause.org
Email a Friend
close
Please enter a valid email address.
255 character limit
Your friend will receive an e-mail invitation to view this page, but we will not store or share this e-mail address with outside parties.

To submit the email please enter the sum of 0 + 7.